NEFL and diabetes mellitus: The CB2R agonist, AM1710, and the CB1R antagonist, SR141716, administered either alone or in combination, rescued ganglions cell axons from diabetes-induced damage in the retina, as shown by neurofilament (immunoreactivity (NFL-IR) (Figure 1A,B).